ADVAXIS
Why Robinhood?
You can watch ADVAXIS and buy or sell other stocks, ETFs, and their options commission-free!About ADXS
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia.
ADXS Key Statistics
Stock Snapshot
ADVAXIS(ADXS) stock is priced at $0.06, giving the company a market capitalization of 25.73M.
On 2026-03-14, ADVAXIS(ADXS) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for ADVAXIS(ADXS) stock has reached 0, versus its average volume of 14.19K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.80.
The stock's 52-week range extends from a low of $0.00 to a high of $0.80.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.